• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human TEX35 Polyclonal Antibody

The antibody against TEX35 was raised in rabbit using the Recombinant Human Testis-expressed protein 35 protein (1-215AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC.

ADC-19851A

The antibody against TEX35 was raised in rabbit using the Recombinant Human Testis-expressed protein 35 protein (1-215AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-19851A ClonalityPolyclonal
Host SpeciesRabbitTarget NameTEX35
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4
Purification Method>95%, Protein G purifiedConjugateNon-conjugated
ApplicationELISA, IHC, WBStorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Testis-expressed protein 35 protein (1-215AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ5T0J7
Background Information
  • Uniprot Id

    Q5T0J7

  • Target Species

    Human

  • Target Name

    TEX35

  • Target Full Name

    Testis-expressed protein 35

  • Target Synonyms

    C1orf49; CA049_HUMAN; Chromosome 1 open reading frame 49; RP5-990P15.1; Testis expressed 35; Testis specific conserved gene 24kDa; TEX35; TSC24; Uncharacterized protein C1orf49

Inquire Rabbit anti-Human TEX35 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification